Skip to main content
GMED logo

Globus Medical, Inc.

GMEDNYSEHealthcareMedical Devices

$78.84Today:- (-)1Y +34.61%

As of Oct 15, 2026 close

Market cap
$10.83B
P/E (TTM)
20.23
Forward P/E
13.44
Dividend yield
-
52-week range
$57.68$101.40
Volume (live)
-
Avg. volume (3M)
1.57M

Globus Medical, Inc. (GMED) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Globus Medical, Inc. stock.

Analyst Consensus Rating

Investment consensus from 18 professional research analysts

Consensus Rating

Buy
Based on 18 unique analysts
(22 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$98.04
+24.35% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest GMED Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Thomas Stephan
Stifel Nicolaus
HoldReiterates
$76.43
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Moumi Mondal
Zacks Equity Research
BuyInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Shagun Singh Chadha
RBC Capital
BuyMaintains
$115.00 → $85.00
Ryan Zimmerman
BTIG
HoldMaintains
-
Swayta Shah
Zacks Equity Research
BuyInitiates Coverage
-
Moumi Mondal
Zacks Equity Research
SellInitiates Coverage
-
Caitlin Roberts
Canaccord Genuity
BuyReiterates
$115.00
Vik Chopra
BMO Capital
BuyMaintains
$94.00
Keith Hinton
Freedom Capital
HoldMaintains
$87.00
Vik Chopra
BMO Capital
BuyMaintains
$94.00
Urmimala Biswas
Zacks Equity Research
BuyInitiates Coverage
-
Travis Steed
BofA Securities
BuyMaintains
$106.00
Thomas Stephan
Stifel Nicolaus
HoldMaintains
$85.00
Matthew O'Brien
Piper Sandler
BuyMaintains
$100.00
Richard Newitter
Truist
BuyReiterates
$100.00
Larry Biegelsen
Wells Fargo
BuyMaintains
$103.00 → $99.00
David Saxon
Needham
BuyReiterates
$117.00
Mathew Blackman
TD Cowen
BuyMaintains
$115.00
Sridatri Sarkar
Zacks Equity Research
HoldInitiates Coverage
-
Patrick Wood
UBS
HoldInitiates
$82.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 7, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for GMED?

The analyst consensus rating for GMED is Buy, based on the latest ratings from 18 analysts over the last 90 days.

What is the average price target for GMED?

The average 12-month price target for GMED is $98.04, representing an upside of 24.4% from the Oct 15, 2026 close of $78.84.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.